SCHEMBL5997176

SCHEMBL5997176

CCOC(=O)C(CCN1C(=O)C(c2ccccc2)=C(c2ccccc2)C1=O)C1(C)OCCO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
ALDH1A1 P00352 8/20 0.37
PPARG P37231 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 3/20 0.35
KDM4E B2RXH2 3/20 0.35
MAPT P10636 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
PTPN1 P18031 2/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
HSP90AA1 P07900 1/20 0.35
MAPK1 P28482 1/20 0.35
MPI P34949 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5997885 0.90 ACHE (0.39) TSHRALDH1A1
SCHEMBL5998838 0.89 ALDH1A1 (0.38) TSHRALDH1A1PPARGLMNAKDM4E
SCHEMBL5996133 0.85 DRD2 (0.40) TSHRALDH1A1LMNAKDM4EMAPT
SCHEMBL5997622 0.82 MEN1 (0.40) TSHRALDH1A1LMNAMAPTMEN1
SCHEMBL5998656 0.79 ALDH1A1 (0.42) TSHRALDH1A1LMNAKDM4EMAPT
SCHEMBL5998394 0.79 ACHE (0.40) ALDH1A1CYP1A2CYP2C9CYP2C19L3MBTL1
SCHEMBL5998659 0.77 RGS4 (0.40) TSHRALDH1A1LMNAKDM4EMAPT
SCHEMBL5998352 0.76 DRD2 (0.43) TSHRALDH1A1LMNAMAPTNPSR1
SCHEMBL5997643 0.73 LMNA (0.40) TSHRALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL5998815 0.73 MMP1 (0.41) LMNAMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7094908-B2 Reduction of carbonyl compounds using the carbonyl reductase of Kluyveromyces marxianus KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2006-08-22 US disclosed
US-20030139464-A1 Reduction of carbonyl compounds using the carbonyl reductase of kluyveromyces marxianus KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139464-A1 Reduction of carbonyl compounds using the carbonyl reductase of kluyveromyces marxianus CBR1, CBR3, DCXR TSHR 3901/4885ALDH1A1 216/4885PPARG 1849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.